AM-2201

115.003,100.00

Clear
SKU: AM-2201 Category:

AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.

Pharmacology

AM-2201 is a full agonist for cannabinoid receptors. Affinities are: with a Ki of 1.0 nM at CB1 and 2.6 nM at CB2. The 4-methyl functional analog MAM-2201 probably has similar affinities.[original research? AM-2201 has an EC50 of 38 nM for human CB1 receptors, and 58 nM for human CB2 receptors. AM-2201 produces bradycardia and hypothermia in rats at doses of 0.3–3 mg/kg, comparable to the potency of JWH-018 in rats, suggesting potent cannabinoid-like activity.

IUPAC name

1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone

CAS Number

335161-24-5

Formula

C24H22FNO

Molar mass

359.444 g·mol−1

Reviews

There are no reviews yet.

Be the first to review “AM-2201”

Your email address will not be published. Required fields are marked *